首页|期刊导航|中国免疫学杂志|TRIM38通过TRAF6-p38MAPK通路调节铁死亡参与心力衰竭的机制研究

TRIM38通过TRAF6-p38MAPK通路调节铁死亡参与心力衰竭的机制研究OA

Mechanism of TRIM38 in heart failure by regulating ferroptosis through TRAF6-p38MAPK pathway

中文摘要英文摘要

目的:探究TRIM38通过TRAF6-p38MAPK通路调节铁死亡参与心力衰竭(HF)的内在机制.方法:通过感染AdshTRIM38腺病毒敲低AC16细胞TRIM38水平,免疫荧光检测心肌细胞形态变化及GPX4表达,Western blot、qRT-PCR检测心房利钠肽(ANP)及脑利钠肽(BNP)蛋白及mRNA表达,Western blot、泛素化及免疫共沉淀(Co-IP)检测TRIM38与TRAF6-p38MAPK通路的相互作用;采用主动脉弓缩窄(TAC)建立HF小鼠模型,分为野生型(WT)组和TRIM38基因敲除(TRIM38-KO)组,术后进行心脏重量测量、组织病理学检查及Western blot、qRT-PCR检测.结果:沉默TRIM38可使AC16细胞尺寸增大,ANP、BNP及GPX4表达增加;TRIM38与TRAF6相互作用并调节其泛素化及p38MAPK磷酸化.体内实验表明,与WT小鼠相比,TAC术后4周TRIM38-KO小鼠心脏重量、心脏重量/体质量和心脏重量/胫骨长度均显著增加.组织病理学结果显示,与TAC-WT组相比,TAC-TRIM38-KO组心肌细胞病理性肥大,心肌纤维化加重.Western blot及qRT-PCR显示TAC-TRIM38-KO组小鼠心脏组织ANP、BNP、MYH7、C ollagen Ⅰa、Collagen Ⅲ及CTGF、p38MAPK磷酸化水平及TRAF6表达显著升高.免疫荧光染色显示 TRIM38-KO 小鼠心肌铁死亡和细胞凋亡增加,且 TRAF6-p38MAPK 通路激活.结 论:TRIM38通过 TRAF6-p38MAPK通路调节铁死亡,参与HF发生发展.

Objective:To explore underlying mechanism by which TRIM38 participates in heart failure(HF)by regulating fer-roptosis through TRAF6-p38MAPK pathway.Methods:TRIM38 level in AC16 cells was knocked down by infecting with AdshTRIM38 adenovirus.Immunofluorescence was used to detect morphological changes of myocardial cells and GPX4 protein expression.Western blot and qRT-PCR were employed to detect protein and mRNA expressions of atrial natriuretic peptide(ANP)and brain natriuretic peptide(BNP).Western blot,ubiquitination and co-immunoprecipitation(Co-IP)were used to detect interaction between TRIM38 and TRAF6-p38MAPK pathway.A transverse aortic constriction(TAC)mouse HF model was established and divided into wild-type(WT)group and TRIM38 gene knockout(TRIM38-KO)group.After surgery,heart weight measurement,histopathological examina-tion,as well as Western blot and RT-qPCR detections were carried out.Results:Silencing TRIM38 increased size of AC16 cells and expressions of ANP,BNP and GPX4.TRIM38 interacted with TRAF6 and regulated its ubiquitination and p38MAPK phosphorylation.In vivo experiments showed that compared with WT mice,at 4 weeks after TAC surgery,heart weight,heart weight/body weight and heart weight/tibia length of TRIM38-KO mice were significantly increased.Histopathological results indicated that compared with TAC-WT group,TAC-TRIM38-KO group exhibited pathological hypertrophy of myocardial cells and aggravated myocardial fibrosis.Western blot and qRT-PCR showed that ANP,BNP,MYH7,Collagen Ⅰ a,Collagen Ⅲ,CTGF expressions,phosphorylation level of p38MAPK,and TRAF6 expression in heart tissue of TAC-TRIM38-KO mice were significantly increased.Immunofluorescence staining of TRIM38-KO mice revealed an increase in myocardial ferroptosis and cell apoptosis,and activation of TRAF6-p38MAPK pathway.Conclusion:TRIM38 participates in occurrence and development of HF by regulating ferroptosis through TRAF6-p38MAPK pathway.

杜海燕;包秋红;贾海玉;刘昀;张勇

内蒙古医科大学附属医院,呼和浩特 010000内蒙古医科大学附属医院,呼和浩特 010000内蒙古医科大学附属医院,呼和浩特 010000内蒙古医科大学附属医院,呼和浩特 010000内蒙古医科大学附属医院,呼和浩特 010000

医药卫生

TRIM38TRAF6p38MAPK铁死亡心力衰竭

TRIM38TRAF6p38MAPKFerroptosisHeart failure

《中国免疫学杂志》 2026 (5)

1078-1083,6

公立医院科研联合基金科技项目(2024GLLH0294).

10.3969/j.issn.1000-484X.2026.05.009

评论